In patients with pancreatic cancer, surgery is the primary modality of treatment. However, surgery is performed only in a small fraction of patients who have resectable lesions.  Majority of patients have unresectable disease and are treated with chemotherapy and/or radiation<unk>  as a part of adjuvant or neoadjuvant<unk> .  Curative resection is not performed in cases of extrapancreatic involvement that require palliative<unk> .  As per the guidelines of The National Comprehensive Cancer Network (NCCN), patients with locally advanced unresectable or metastatic disease should be treated with a combination of Leucovorin, 5-fuorouracil, Oxaliplatin, and Irinotecan also known as FOLFIRINOX regimen. Neoadjuvant<unk>  is preferred as shrinkage of the tumor using chemotherapy makes resection easier and improves patient prognosis. Radiotherapy may also form part of neoadjuvant<unk>  to facilitate tumor shrinkage, but its use on unresectable tumors remains controversial.
Pancreatic cancer medical therapy
Pancreatic cancer chemotherapy
Pancreatic cancer radiation therapy
Pancreatic cancer surgery
Stomach cancer medical therapy
Gallbladder cancer medical therapy
Fatty liver medical therapy
Hereditary pancreatitis medical therapy